Valuation: AbClon Inc.

Market Cap 559B 396M 343M 320M 294M 552M 37.72B 561M 3.76B 1.47B 18.91B 1.49B 1.46B 62.51B P/E 2024
-14.5x
P/E 2025 -43.5x
Enterprise Value 521B 369M 320M 298M 274M 515M 35.16B 523M 3.5B 1.37B 17.62B 1.39B 1.36B 58.26B EV / Sales 2024
103x
EV / Sales 2025 164x
Free-Float
80.08%
Yield 2024 *
-
Yield 2025 -
1 day+2.56%
1 week+62.04%
Current month+42.13%
1 month+9.16%
3 months-39.20%
6 months-52.86%
Current year-34.12%
1 week 19,220
Extreme 19220
28,650
1 month 16,250
Extreme 16250
28,650
Current year 16,250
Extreme 16250
95,800
1 year 9,770
Extreme 9770
95,800
3 years 6,810
Extreme 6810
95,800
5 years 6,810
Extreme 6810
95,800
10 years 6,810
Extreme 6810
95,800
Manager TitleAgeSince
Chief Executive Officer 63 24/06/2010
Director of Finance/CFO 59 27/03/2024
Chief Tech/Sci/R&D Officer 57 28/03/2023
Director TitleAgeSince
Director/Board Member 63 -
Director/Board Member 62 28/03/2021
Director/Board Member 57 28/03/2023
Change 5-day change 1-year change 3-year change Capi.($)
+2.56%+62.04%+157.59%+55.64% 383M
+1.24%+2.20%+39.22%+0.60% 77.1B
-0.84%+0.09%+20.92%+179.15% 49.43B
+2.77%+1.90%-1.84%+27.14% 49.27B
-0.13%+3.33%-50.97%-50.14% 44.59B
-0.19%+1.27%+60.88%-24.22% 30.48B
+1.19%+0.46%+53.54%+84.97% 24B
+7.06%+4.68%+115.65%-43.30% 21.5B
+4.29%+7.66%-3.26%+189.18% 20.18B
+1.66%-3.70%+65.40%+123.91% 16.29B
Average +1.97%+3.46%+45.71%+54.29% 33.32B
Weighted average by Cap. +1.43%+2.61%+25.15%+42.71%

Financials

2024 2025
Net sales 2.34B 1.66M 1.44M 1.34M 1.23M 2.31M 158M 2.35M 15.73M 6.18M 79.19M 6.23M 6.1M 262M 4.71B 3.34M 2.89M 2.7M 2.48M 4.66M 318M 4.74M 31.7M 12.44M 160M 12.56M 12.28M 527M
Net income -16.3B -11.57M -10M -9.34M -8.57M -16.12M -1.1B -16.38M -110M -43.02M -552M -43.43M -42.48M -1.82B -17.91B -12.7M -10.99M -10.26M -9.41M -17.71M -1.21B -17.99M -120M -47.26M -606M -47.71M -46.67M -2B
Net Debt -4.61B -3.27M -2.83M -2.64M -2.42M -4.56M -311M -4.63M -31.01M -12.17M -156M -12.29M -12.02M -516M -37.93B -26.91M -23.28M -21.74M -19.94M -37.5M -2.56B -38.1M -255M -100M -1.28B -101M -98.83M -4.24B
Logo AbClon Inc.
AbClon Inc is a Korea-based company principally engaged in the development, manufacture and distribution of antibody drug. The Company developed a bio synergy antibody, a therapeutic antibody for a new mechanism that is different from conventional therapeutic agents, and is based on the YPLUS and AffiMab platforms. The company's products include AC101, AC103, AC104, AC106, AC203, AM201, AM101, AM102 and AM103. The Company distributes its products within domestic market and to overseas markets.
Employees
-
Date Price Change Volume
06/08/26 28,000.00 +2.56% 148,989
06/08/26 ₩27,300.00 +4.20% 226,005
05/08/26 ₩26,200.00 -1.13% 184,558
04/08/26 ₩26,500.00 +20.73% 499,801
03/08/26 ₩21,950.00 +11.42% 146,070
  1. Stock Market
  2. Stocks
  3. A174900 Stock